Etomidate and Pepcid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Etomidate (etomidate) and Pepcid (famotidine). Common drug interactions include depression among females and pain among males.

The phase IV clinical study analyzes what interactions people have when they take Etomidate and Pepcid. It is created by eHealthMe based on reports of 75 people who take the same drugs from the FDA, and is updated regularly.

What is Etomidate?

Etomidate has active ingredients of etomidate. eHealthMe is studying from 2,496 Etomidate users. Check the latest studies of Etomidate.

What is Pepcid?

Pepcid has active ingredients of famotidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 55,774 Pepcid users. Check the latest studies of Pepcid.

On Jul, 11, 2026

75 people who take Etomidate and Pepcid together, and have interactions are studied.

What are the common drug interactions of Etomidate and Pepcid, by gender? *:

female:

Depression
Renal failure acute (rapid kidney dysfunction)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Bone disorder
Disability
Thrombocytopenia (decrease of platelets in blood)
Tooth fracture
Adnexa uteri mass (ovarian cysts)
Arthralgia (joint pain)
Balance disorder

male:

Pain
Anxiety
Alopecia (absence of hair from areas of the body)
Asthenia (weakness)
Back pain
Bone disorder
Cardiac murmur (an heart sound in valve abnormality)
Cervicobrachial syndrome (pain in neck and arm with changing location)
Decreased interest
Dental caries

What are the common drug interactions of Etomidate and Pepcid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Acute respiratory distress syndrome
Agitation (state of anxiety or nervous excitement)
Back pain
Blood phosphorus decreased
Bradycardia (abnormally slow heart action)
Hypocalcaemia (levels of calcium in blood serum are abnormally low)
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
Leukocytosis (increased white blood cells)
Respiratory acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease)
Hyperglycaemia (high blood sugar)

30-39:

n/a

40-49:

Anxiety
Pain
Depression
Injury
Alopecia (absence of hair from areas of the body)
Asthenia (weakness)
Back pain
Bone disorder
Cardiac murmur (an heart sound in valve abnormality)
Chest pain

50-59:

Nausea (feeling of having an urge to vomit)
Renal failure chronic (long lasting kidney dysfunction)
Syncope (loss of consciousness with an inability to maintain postural tone)
Unresponsive to stimuli
Anxiety
Blood disorder
Cardiac failure
Coagulopathy (blood's ability to clot is impaired)
Death
Emotional distress

60+:

Pain
Injury
Sepsis (a severe blood infection that can lead to organ failure and death)
Abdominal pain
Adnexa uteri mass (ovarian cysts)
Arthralgia (joint pain)
Balance disorder
Bone disorder
Contusion (a type of hematoma of tissue in which capillaries)
Disability

What are the existing conditions these people have? *

Pain: 14 people, 18.67%
High Blood Pressure: 9 people, 12.00%
Prostate Cancer: 8 people, 10.67%
Weakness: 7 people, 9.33%
Sedation: 7 people, 9.33%
Hypoaesthesia (reduced sense of touch or sensation): 7 people, 9.33%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 8.00%
Abdominal Infection: 5 people, 6.67%
Urinary Tract Infection: 4 people, 5.33%
Pulmonary Embolism (blockage of the main artery of the lung): 4 people, 5.33%

* Approximation only. Some reports may have incomplete information.

Do you take Etomidate and Pepcid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously